本页面由Tiger Trade Technology Pte. Ltd.提供服务

Protagonist Therapeutics Inc

86.82
+4.064.90%
成交量:46.95万
成交额:3,976.87万
市值:54.27亿
市盈率:131.54
高:86.82
开:82.32
低:77.00
收:82.76
52周最高:96.54
52周最低:33.70
股本:6,251.57万
流通股本:4,315.48万
量比:1.19
换手率:1.09%
股息:- -
股息率:- -
每股收益(TTM):0.6600
每股收益(LYR):4.23
净资产收益率:7.80%
总资产收益率:1.82%
市净率:8.41
市盈率(LYR):20.52

数据加载中...

2026/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2025/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/10/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/06

重要事件披露

Form 8-K - Current report
2025/07/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

重要事件披露

Form 8-K - Current report